12:00 AM
 | 
Dec 04, 2000
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Lorus preclinical data

LOR said that in mice with human pancreatic cancer resistant to Eli Lilly and Co.'s Gemzar...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >